Glasgow Coma Scale ≤ 12 at Admission is a Predictor of Poor Functional Outcome (mRS 2-6) at One Year in Patients with Cerebral Venous Thrombosis.
Adult
Anticoagulants
/ therapeutic use
Anticonvulsants
/ therapeutic use
Disability Evaluation
Female
Functional Status
Glasgow Coma Scale
Humans
Male
Patient Admission
Predictive Value of Tests
Prognosis
Prospective Studies
Recovery of Function
Retrospective Studies
Risk Assessment
Risk Factors
Sinus Thrombosis, Intracranial
/ diagnosis
Time Factors
Venous Thrombosis
/ diagnosis
Cerebral venous thrombosis
Complications
Functional outcome
Glasgow coma scale
mRS
Journal
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
21
01
2021
revised:
21
03
2021
accepted:
01
04
2021
pubmed:
30
4
2021
medline:
17
6
2021
entrez:
29
4
2021
Statut:
ppublish
Résumé
To determine factors at hospitalization of cerebral venous thrombosis (CVT) which determine outcome at one year. This was an ambispective study with outcome at one year follow up. Patients angiographically proven as CVT were included in study and functional modified Rankin Scale (mRS) determined at one year. They were dichotomized into "good" outcome (mRS 0-1) and "poor" outcome (mRS 2-6). Variables at admission were compared on univariate and then by cox proportional hazard regression for significance. Complications during follow up period were also compared. One hundred and seventy five patients were included, data of 71 was collected prospectively. One hundred and seventeen (66.9%) had "good" outcome while 58 (33.1%) had "poor" outcome. Univariate analysis showed poor outcome associated with age < 30 years, female sex, focal deficit, GCS ≤ 12, ≥3 sinuses involved and intracerebral haemorrhage. On Cox proportional hazard regression only GCS ≤ 12 was significant. Around 96% had complete/ partial recanalization at 6 months. Over one year, the complications included dural AV fistula in 10 (5.7%), intracranial hypertension in 4 (2.3%), venous thromboembolism in 6 (3.4%) and arterial infarct in 4 (2.3%). Proportions with complications in each group were similar. At one year 41 patients (25.2%) were continued on anticoagulation and 97 (55.2%) on antiepileptic drugs. Proportion in each group were similar. In patients with CVT, GCS ≤ 12 at admission was a predictor of poor functional outcome (mRS 2-6) at one year. During this period, complications were few and similar in the both the groups.
Identifiants
pubmed: 33915391
pii: S1052-3057(21)00214-7
doi: 10.1016/j.jstrokecerebrovasdis.2021.105811
pii:
doi:
Substances chimiques
Anticoagulants
0
Anticonvulsants
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
105811Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None